Preparation of ~(99)Tc~m-DTPA-Folate and biodistribution study in athymic mice
Zhu Jian-hua
Abstract
Zhu Jian-hua
Abstract
The purpose of this article is to study the preparation and biodistribution of Tcm-DTPA-folate in nude 99 mice with a human tumor cell implant. DTPA-folate was synthesized by conjugating folic acid to diethylenetriaminepentaacetic(DTPA), then radiolabeled with 99Tcm. The radio-chemical purity and stability were evaluated. The biodistribution of Tcm-DTPA-folate in nude mice with a human tumor cell implant was studied. The 99 result showed that the radiolabelling yield of Tcm-DTPA-folate was as high as 98%. After 4 h at room temperature, 99 the radiochemical purity of Tcm-DTPA-folate was still over 90%. Tcm-DTPA-folate conjugation showed marked 99 99 tumor-specific deposition in vivo. The tumor-to-muscle ratio at 8 h post intraperitoneal injection was 7.5. 99Tcm-DTPA-folate appears to be a potential radiopharmaceutical for targeting tumor-associated folate receptor.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The purpose of this article is to study the preparation and biodistribution of Tcm-DTPA-folate in nude 99 mice with a human tumor cell implant. DTPA-folate was synthesized by conjugating folic acid to diethylenetriaminepentaacetic(DTPA), then radiolabeled with 99Tcm. The radio-chemical purity and stability were evaluated. The biodistribution of Tcm-DTPA-folate in nude mice with a human tumor cell implant was studied. The 99 result showed that the radiolabelling yield of Tcm-DTPA-folate was as high as 98%. After 4 h at room temperature, 99 the radiochemical purity of Tcm-DTPA-folate was still over 90%. Tcm-DTPA-folate conjugation showed marked 99 99 tumor-specific deposition in vivo. The tumor-to-muscle ratio at 8 h post intraperitoneal injection was 7.5. 99Tcm-DTPA-folate appears to be a potential radiopharmaceutical for targeting tumor-associated folate receptor.
Key concepts: Biodistribution, Folate receptor, Chemistry, In vivo, Radiochemistry, Folic acid, Tissue distribution, Nuclear medicine